Physician profile
John Lace
NPI 1104840461
$1,772.96
in general payments reported to CMS, 2019-2025
10 companies · $66.92 in 2025
The $66.92 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $304 · 2020: $538 · 2021: $550 · 2022: $193 · 2024: $120 · 2025: $66.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $187.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $187.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,006.47 | 2019-2025 | Nucala |
| Advanced Respiratory, INC | $217.92 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $210.23 | 2019-2022 | |
| Mallinckrodt Hospital Products INC. | $100.13 | 2024 | Terlivaz |
| Takeda Pharmaceuticals U.S.A., INC. | $71.10 | 2020-2021 | |
| Baxter Healthcare | $51.33 | 2022 | |
| Genzyme Corporation | $48.24 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $40.30 | 2021 | |
| Abbvie INC. | $14.53 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $12.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Lace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.